← All diseases

Disease Atlas / Disease detail

Pulmonary hypertension

A conservative overview of the causes, symptoms, diagnosis, and management of disease groups that can burden the heart due to increased pulmonary artery pressure.

pulmonary hypertension

MONDO:0005149Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · f663d02a59ca

Disease category
Pulmonary hypertension is a group of diseases characterized by elevated blood pressure in the pulmonary arteries compared to normal levels, including pulmonary arterial hypertension (PAH).
Key mechanism
It may be associated with heart disease, lung disease, sleep apnea, thromboembolism, connective tissue disease, certain liver and hematologic diseases, and exposure to specific drugs or substances; in some cases, the cause is unknown.
Main causes/related factors
When pulmonary arteries are damaged, narrowed, or blocked, blood flow resistance and pulmonary artery pressure increase, making it more difficult for the heart to pump blood to the lungs.
Representative patterns
Typical manifestations include dyspnea during exercise or persistent dyspnea, chest pain or chest tightness, fatigue, dizziness/syncope, palpitations, and edema of the legs, feet, and abdomen.
Individual differences
Risk may vary depending on age, female sex, family history/genetic factors, smoking and illicit drug use, specific infections/environmental exposures, and related heart/lung diseases.
Diagnosis
Symptoms may resemble those of other diseases, potentially delaying diagnosis; if the condition worsens, arrhythmia, thrombosis, pulmonary hemorrhage, heart failure, liver damage, and pregnancy complications may occur.
Management
Diagnosis is conducted by comprehensively integrating cardiac and pulmonary imaging, electrocardiography (ECG), and blood tests, based on the confirmation of medical history and symptoms, physical examination, and assessment of oxygen saturation.
Treatment/Research Status
Pulmonary hypertension cannot be confirmed by symptoms alone; test results must be interpreted in conjunction with the underlying disease and cardiac and pulmonary function.
Read Evidence
Management is carried out by combining lifestyle adjustments, physical activity and pulmonary rehabilitation, medication, oxygen therapy, and necessary procedures, tailored to the cause of pulmonary hypertension and the individual's condition.
Key Precautions
Current treatment is mostly focused on reducing symptoms and burden and managing the condition rather than achieving a complete cure, with choices varying depending on the cause and severity.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a Glance

Pulmonary hypertension is a group of diseases characterized by elevated blood pressure in the pulmonary arteries compared to normal levels, including pulmonary arterial hypertension (PAH).

Typical manifestations include dyspnea during exercise or persistent dyspnea, chest pain or chest tightness, fatigue, dizziness/syncope, palpitations, and edema of the legs, feet, and abdomen.

How the disease works

It may be associated with heart disease, lung disease, sleep apnea, thromboembolism, connective tissue disease, certain liver and hematologic diseases, and exposure to specific drugs or substances; in some cases, the cause is unknown.

When pulmonary arteries are damaged, narrowed, or blocked, blood flow resistance and pulmonary artery pressure increase, making it more difficult for the heart to pump blood to the lungs.

Variations in presentation among individuals

Risk may vary depending on age, female sex, family history/genetic factors, smoking and illicit drug use, specific infections/environmental exposures, and related heart/lung diseases.

The broad framework of diagnosis and management

Symptoms may resemble those of other diseases, potentially delaying diagnosis; if the condition worsens, arrhythmia, thrombosis, pulmonary hemorrhage, heart failure, liver damage, and pregnancy complications may occur.

Diagnosis is conducted by comprehensively integrating cardiac and pulmonary imaging, electrocardiography (ECG), and blood tests, based on the confirmation of medical history and symptoms, physical examination, and assessment of oxygen saturation.

Current status of treatment

Pulmonary hypertension cannot be confirmed by symptoms alone; test results must be interpreted in conjunction with the underlying disease and cardiac and pulmonary function.

Management is carried out by combining lifestyle adjustments, physical activity and pulmonary rehabilitation, medication, oxygen therapy, and necessary procedures, tailored to the cause of pulmonary hypertension and the individual's condition.

Current treatment is mostly focused on reducing symptoms and burden and managing the condition rather than achieving a complete cure, with choices varying depending on the cause and severity.

How to read clinical trials

The NCT03707561 record in the packet is registered as an observational study related to pulmonary hypertension; however, because its status is unclear and there are no results, it does not demonstrate treatment efficacy or standard care.

Points to verify during clinical consultations

In clinical practice, one can verify the onset and changes in symptoms, presence of syncope, chest pain, or edema, underlying heart/lung disease, thrombosis/family history, current medications and smoking/drug exposure, pregnancy plans, and the significance of test results.

Medical Guidance

This material is for educational purposes and does not replace individual diagnosis or treatment, nor does it provide individual clinical guidelines.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.